These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 1510592)
21. The influence of chemical structure on the extent and sites of carcinogenesis for 522 rodent carcinogens and 55 different human carcinogen exposures. Ashby J; Paton D Mutat Res; 1993 Mar; 286(1):3-74. PubMed ID: 7678908 [TBL] [Abstract][Full Text] [Related]
22. Prediction of mutagenicity and carcinogenicity using in silico modelling: A case study of polychlorinated biphenyls. Vračko M; Bobst S SAR QSAR Environ Res; 2015; 26(7-9):667-82. PubMed ID: 26329919 [TBL] [Abstract][Full Text] [Related]
23. Structure-activity relationship studies of chemical mutagens and carcinogens: mechanistic investigations and prediction approaches. Benigni R Chem Rev; 2005 May; 105(5):1767-800. PubMed ID: 15884789 [No Abstract] [Full Text] [Related]
24. Mutagenicity of nitro- and amino-substituted carbazoles in Salmonella typhimurium. II. Ortho-aminonitro derivatives of 9H-carbazole. André V; Boissart C; Sichel F; Gauduchon P; Le Talaër JY; Lancelot JC; Robba M; Mercier C; Chemtob S; Raoult E Mutat Res; 1995 Nov; 345(1-2):11-25. PubMed ID: 8524352 [No Abstract] [Full Text] [Related]
25. Structural evidence for a dichotomy in rodent carcinogenesis: involvement of genetic and cellular toxicity. Rosenkranz HS; Klopman G Mutat Res; 1993 Oct; 303(2):83-9. PubMed ID: 7692282 [TBL] [Abstract][Full Text] [Related]
26. Relative stabilities of nitrenium ions derived from heterocyclic amine food carcinogens: relationship to mutagenicity. Ford GP; Griffin GR Chem Biol Interact; 1992 Jan; 81(1-2):19-33. PubMed ID: 1730146 [TBL] [Abstract][Full Text] [Related]
27. Quantitative structure-activity relationship investigation of the role of hydrophobicity in regulating mutagenicity in the Ames test: 2. Mutagenicity of aromatic and heteroaromatic nitro compounds in Salmonella Typhimurium TA100. Debnath AK; Lopez de Compadre RL; Shusterman AJ; Hansch C Environ Mol Mutagen; 1992; 19(1):53-70. PubMed ID: 1732104 [TBL] [Abstract][Full Text] [Related]
28. Structural and mechanistic bases for the induction of mitotic chromosomal loss and duplication ('malsegregation') in the yeast Saccharomyces cerevisiae: relevance to human carcinogenesis and developmental toxicology. Liu M; Grant SG; Macina OT; Klopman G; Rosenkranz HS Mutat Res; 1997 Mar; 374(2):209-31. PubMed ID: 9100845 [TBL] [Abstract][Full Text] [Related]
29. QSAR screening of 70,983 REACH substances for genotoxic carcinogenicity, mutagenicity and developmental toxicity in the ChemScreen project. Wedebye EB; Dybdahl M; Nikolov NG; Jónsdóttir SÓ; Niemelä JR Reprod Toxicol; 2015 Aug; 55():64-72. PubMed ID: 25797653 [TBL] [Abstract][Full Text] [Related]
31. Exploring structure-activity relationships of mutagens and carcinogens. Benigni R Prog Clin Biol Res; 1991; 372():59-67. PubMed ID: 1956948 [No Abstract] [Full Text] [Related]
32. Putting the Predictive Toxicology Challenge into perspective: reflections on the results. Benigni R; Giuliani A Bioinformatics; 2003 Jul; 19(10):1194-200. PubMed ID: 12835261 [TBL] [Abstract][Full Text] [Related]
33. Salmonella mutagenicity tests: V. Results from the testing of 311 chemicals. Zeiger E; Anderson B; Haworth S; Lawlor T; Mortelmans K Environ Mol Mutagen; 1992; 19 Suppl 21():2-141. PubMed ID: 1541260 [TBL] [Abstract][Full Text] [Related]
34. International Commission for Protection Against Environmental Mutagens and Carcinogens. The subtlety of alkylating agents in reactions with biological macromolecules. Vogel EW; Nivard MJ Mutat Res; 1994 Feb; 305(1):13-32. PubMed ID: 7508544 [TBL] [Abstract][Full Text] [Related]
35. Mutagens that are not carcinogens: faulty theory or faulty tests? Zeiger E Mutat Res; 2001 May; 492(1-2):29-38. PubMed ID: 11377241 [TBL] [Abstract][Full Text] [Related]
36. A structural analysis of the genotoxic and carcinogenic potentials of cyclosporin A. Rosenkranz HS; Klopman G Mutagenesis; 1992 Mar; 7(2):115-8. PubMed ID: 1579066 [TBL] [Abstract][Full Text] [Related]
37. Comparison of criteria used to access carcinogenicity in CPANN QSAR models versus the knowledge-based expert system Toxtree. Fjodorova N; Novič M SAR QSAR Environ Res; 2014; 25(6):423-41. PubMed ID: 24716754 [TBL] [Abstract][Full Text] [Related]
38. Carcinogenicity of the aromatic amines: from structure-activity relationships to mechanisms of action and risk assessment. Benigni R; Passerini L Mutat Res; 2002 Jul; 511(3):191-206. PubMed ID: 12088717 [TBL] [Abstract][Full Text] [Related]
39. BTS working party report on in vitro toxicology. Fielder RJ; Atterwill CK; Anderson D; Boobis AR; Botham P; Chamberlain M; Combes R; Duffy PA; Lewis RW; Lumley CE; Kimber I; Newall DR Hum Exp Toxicol; 1997 Nov; 16 Suppl 1():S1-40. PubMed ID: 9429089 [No Abstract] [Full Text] [Related]
40. Risk identification using structural concepts: the potential carcinogenicity of praziquantel. Rosenkranz HS; Zhang YP; Klopman G Regul Toxicol Pharmacol; 1995 Oct; 22(2):152-61. PubMed ID: 8577950 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]